Market Overview:
The global COVID-19 detection kits market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of COVID-19, rising awareness about the disease, and technological advancements in detection kits. The global COVID-19 detection kit market is segmented on the basis of type, application, and region. On the basis of type, it is divided into injection and topical. Injection kits are further classified into ELISA test kit and rapid test kit. Topical kits are further classified into swab test kit and nasal wash test kit. On the basis of application, it is divided into hospital clinics drug store others). Geographically, it is analyzed across North America Latin America Europe Asia Pacific Middle East & Africa).
Product Definition:
A COVID-19 detection kit is a device used to identify the presence of the coronavirus in a sample. The kits are important for identifying and diagnosing cases of COVID-19.
Injection:
Injection is a technique used to transfer genetic material into an organism's DNA, RNA, or cells. It is also used for the delivery of chemical substances to living tissues and organs. Injection can be performed by various methods including calcium phosphate transfection, liposomes (including nanoliposomes), electroporation, microinjection, and biolistic attack.
Topical:
Topical is a term used for medications that are applied to the skin. Topical drugs can be easily administered in comparison with other forms of medication such as intravenous and oral. The most common topical medications include creams, ointments, lotions, transdermal patches, gels and sprays.
The high concentration of active ingredients in the topical drug allows it to quickly reach the site of action which helps in reducing pain or inflammation or even infection if any.
Application Insights:
The hospital application segment led the global COVID-19 detection kits market in 2017. The rapid response and active surveillance phases of COVID-19 infection have resulted in a large number of patients being admitted to hospitals for diagnosis and treatment. This trend is expected to continue over the coming weeks as more cases are reported. As a result, demand for diagnostic tests is anticipated to increase at hospitals, which in turn is likely to drive growth at a lucrative rate during the forecast period.
Clinics are estimated to be the fastest growing application segment over the forecast period owing to an increasing number of clinics that offer diagnostic services relatedto various infectious diseases including coxackievirus A&B infections, adenovirus infections, rhinovirus infections etcetera.
Regional Analysis:
North America dominated the global market in 2018 owing to the presence of a large number of COVID-19 positive cases in this region. The U.S., which is at the forefront, accounted for more than half of all cases across the globe. Europe followed North America with 19% share in terms of revenue and is expected to grow significantly over the forecast period due to its early adoption of COVID-19 tests and rapid development healthcare infrastructure coupled with high patient awareness levels regarding these tests. Asia Pacific regional market was valued at USD X million in 2018 and is anticipated to witness lucrative growth over next eight years owing to increasing investments by governments as well as private players for developing healthcare facilities, thereby creating numerous opportunities for industry players operating within this region.
Growth Factors:
- Increasing demand for COVID-19 detection kits from hospitals, diagnostic laboratories, and research institutes for early diagnosis of the disease.
- Rising awareness about the benefits of using COVID-19 detection kits for accurate diagnosis and treatment of the disease.
- Technological advancements in COVID-19 detection kits that offer enhanced accuracy and speed of diagnosis.
- Growing number of outbreaks and pandemics due to SARS-CoV-2 (the virus that causes COVID-19) across the world, which is driving demand for COVID-19 detection kits globally.
Scope Of The Report
Report Attributes
Report Details
Report Title
COVID-19 Detection Kits Market Research Report
By Type
Injection, Topical
By Application
Hospital, Clinics, Drug Store, Others
By Companies
Merck, Roche, SP (Brinny) Company, Anke Bio, Sinopharm, Kexing Biopharm, Kawin, Hainan Unipul Pharmaceutical, Tri-Prime Gene, Amoytop Biotech, Changchun Institute of Biological Products
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
162
Number of Tables & Figures
114
Customization Available
Yes, the report can be customized as per your need.
Global COVID-19 Detection Kits Market Report Segments:
The global COVID-19 Detection Kits market is segmented on the basis of:
Types
Injection, Topical
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinics, Drug Store, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- Roche
- SP (Brinny) Company
- Anke Bio
- Sinopharm
- Kexing Biopharm
- Kawin
- Hainan Unipul Pharmaceutical
- Tri-Prime Gene
- Amoytop Biotech
- Changchun Institute of Biological Products
Highlights of The COVID-19 Detection Kits Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Injection
- Topical
- By Application:
- Hospital
- Clinics
- Drug Store
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the COVID-19 Detection Kits Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The COVID-19 Detection Kits are a set of tools that allow for the detection and characterization of coronavirus strains. The kits include a variety of reagents and equipment necessary for the analysis of coronavirus samples.
Some of the major players in the covid-19 detection kits market are Merck, Roche, SP (Brinny) Company, Anke Bio, Sinopharm, Kexing Biopharm, Kawin, Hainan Unipul Pharmaceutical, Tri-Prime Gene, Amoytop Biotech, Changchun Institute of Biological Products.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 COVID-19 Detection Kits Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 COVID-19 Detection Kits Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 COVID-19 Detection Kits Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the COVID-19 Detection Kits Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global COVID-19 Detection Kits Market Size & Forecast, 2020-2028 4.5.1 COVID-19 Detection Kits Market Size and Y-o-Y Growth 4.5.2 COVID-19 Detection Kits Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Injection
5.2.2 Topical
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinics
6.2.3 Drug Store
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global COVID-19 Detection Kits Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 COVID-19 Detection Kits Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Injection
9.6.2 Topical
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinics
9.10.3 Drug Store
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Injection
10.6.2 Topical
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinics
10.10.3 Drug Store
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Injection
11.6.2 Topical
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinics
11.10.3 Drug Store
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Injection
12.6.2 Topical
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinics
12.10.3 Drug Store
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Injection
13.6.2 Topical
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinics
13.10.3 Drug Store
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 COVID-19 Detection Kits Market: Competitive Dashboard
14.2 Global COVID-19 Detection Kits Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 Roche
14.3.3 SP (Brinny) Company
14.3.4 Anke Bio
14.3.5 Sinopharm
14.3.6 Kexing Biopharm
14.3.7 Kawin
14.3.8 Hainan Unipul Pharmaceutical
14.3.9 Tri-Prime Gene
14.3.10 Amoytop Biotech
14.3.11 Changchun Institute of Biological Products